NCT05977218Recruiting
DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients Trial
Source: ClinicalTrials.gov · Last updated 25 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This randomized controlled trial will assess the impact of the FoodSwitch mobile app, which provides interpretive front-of-pack labelling via barcode scanning, in 900 Swedish adults with type 2 diabetes. Participants will be randomized to app + standard advice or standard advice alone. The primary outcome is change in HbA1c at 6 months; secondary outcomes include anthropometrics, quality of life, medication use, hospitalizations, and mortality.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 900 (estimated)
- First submitted
- 6 Jul 2023
- Start date
- Aug 2025
- Primary completion date
- Dec 2026
- Lead sponsor
- Linkoeping University
- Diseases
- Type 2 diabetes
- NCT number
- NCT05977218
What you commit to
- Study type: Interventional
- Planned participants: 900
- From Aug 2025 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Failure to complete eligibility screening and run-in periods
Other
- No access to BankID (a digital identification system commonly used in Sweden)
Who the study is looking for
- Age between 18 and 75 years
- Self-reported type 2 diabetes with a duration of ≥2 years
- Regularly grocery shopping
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Linköping University Coordinator of this site? Confirm its status | Linköping | Sweden | Recruiting |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.